---
title: "688410.SH (688410.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688410.SH/news.md"
symbol: "688410.SH"
name: "688410.SH"
parent: "https://longbridge.com/en/quote/688410.SH.md"
datetime: "2026-03-14T22:59:10.147Z"
locales:
  - [en](https://longbridge.com/en/quote/688410.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688410.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688410.SH/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/688410.SH/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/688410.SH/news.md)


# 688410.SH (688410.SH) — Related News

### [SWS Medical: Net profit in 2025 increased by 101.89% year-on-year](https://longbridge.com/en/news/277176032.md)
*2026-02-27T09:42:39.000Z*
> SWS Medical announced that the company achieved a total operating revenue of 806.8215 million yuan in 2025, an increase 

### [SWS Medical to showcase blood purification solutions at Dubai WHX Expo from Feb 9-12, 2026. Booth N°37.D70-01.](https://longbridge.com/en/news/275259141.md)
*2026-02-09T03:02:02.000Z*
> SWS Medical, based in Chongqing, China, will showcase its blood purification solutions at the Dubai World Health (WHX) E

### [22:00 ETSWS Medical Brings Next-Generation Blood Purification Solutions to WHX Dubai 2026](https://longbridge.com/en/news/275257316.md)
*2026-02-09T03:00:39.000Z*
> SWS Medical will showcase its next-generation blood purification solutions at the Dubai World Health Expo 2026, marking 

### [SWS Medical issued a profit forecast, expecting a net profit attributable to the parent company of 140 million to 159 million yuan in 2025, an increase of 98% to 125% year-on-year](https://longbridge.com/en/news/274280715.md)
*2026-01-30T09:15:37.000Z*
> SWS Medical expects a net profit attributable to the parent company of 140 million to 159 million yuan in 2025, an incre

### [SWS Medical shareholder Liu Yunjun plans to reduce holdings by no more than 1% of shares](https://longbridge.com/en/news/272704420.md)
*2026-01-15T13:27:04.000Z*
> SWS Medical announced that its major shareholder Liu Yunjun plans to reduce his holdings by no more than 3.196 million s

### [SWS Medical: Disclosure of results after the expiration of the major shareholder and senior management's share reduction plan](https://longbridge.com/en/news/272236326.md)
*2026-01-12T08:13:39.000Z*
> SWS Medical announced that the share reduction plan of its major shareholder, Dajiankang, and executive Ren Yingxiang wa

### [SWS Medical shareholders plan to reduce their holdings by no more than 2%](https://longbridge.com/en/news/271652394.md)
*2026-01-06T12:51:04.000Z*
> SWS Medical announced that shareholders Yuan Wai Yuan, Chongqing De Xiang, and Chongqing De Rui plan to reduce their hol